Terms: = Leukemia AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
28 results:
1. Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Lu X; Emond B; Qureshi ZP; Wu LH; Forbes SP; Hilts A; Liu S; Lafeuille MH; Lefebvre P; Huang Q; Rogers KA
Curr Med Res Opin; 2023 Sep; 39(9):1227-1235. PubMed ID: 37530387
[TBL] [Abstract] [Full Text] [Related]
2. Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.
Roeker LE; DerSarkissian M; Ryan K; Chen Y; Duh MS; Wahlstrom SK; Hakre S; Yu L; Guo H; Mato AR
Blood Adv; 2023 Aug; 7(16):4291-4301. PubMed ID: 37163361
[TBL] [Abstract] [Full Text] [Related]
3. Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
Atallah E; Mauro MJ; Hochhaus A; Boquimpani C; Minami Y; Maheshwari VK; Saini L; Corbin R; Réa D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6247-6262. PubMed ID: 36707445
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Persistence and Time to Next treatment With Ibrutinib in Patients With Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
Narezkina A; Akhter N; Lu X; Emond B; Panjabi S; Forbes SP; Hilts A; Liu S; Lafeuille MH; Lefebvre P; Huang Q; Choi M
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e959-e971. PubMed ID: 35973891
[TBL] [Abstract] [Full Text] [Related]
5. Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction model.
Oh BLZ; Fan L; Lee SHR; Foo KM; Chiew KH; Seeto ZZL; Chen ZW; Neoh CCC; Liew GSM; Eng JJ; Lam JCM; Quah TC; Tan AM; Chan YH; Yeoh AEJ
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e456-e468. PubMed ID: 35134276
[TBL] [Abstract] [Full Text] [Related]
6. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
Agrawal R; Goel V; Anand A; Arora RS
Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
[TBL] [Abstract] [Full Text] [Related]
7. Lack of association between functional polymorphism of DNA repair genes (XRCC1, xpd) and clinical response in Indian chronic myeloid leukemia patients.
Dhangar S; Shanbhag V; Shanmukhaiah C; Vundinti BR
Mol Biol Rep; 2019 Oct; 46(5):4997-5003. PubMed ID: 31286393
[TBL] [Abstract] [Full Text] [Related]
8. Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m
Moreau P; Kumar S; Boccia R; Iida S; Goldschmidt H; Cocks K; Trigg A; Zahlten-Kumeli A; Yucel E; Panjabi SS; Dimopoulos M
Leukemia; 2019 Dec; 33(12):2934-2946. PubMed ID: 31092895
[TBL] [Abstract] [Full Text] [Related]
9. Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Topp MS; Zimmerman Z; Cannell P; Dombret H; Maertens J; Stein A; Franklin J; Tran Q; Cong Z; Schuh AC
Blood; 2018 Jun; 131(26):2906-2914. PubMed ID: 29739753
[TBL] [Abstract] [Full Text] [Related]
10. Influence of XPC, xpd, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract] [Full Text] [Related]
11. Presentation of childhood cancers to a paediatric shared care unit.
Roskin J; Diviney J; Nanduri V
Arch Dis Child; 2015 Dec; 100(12):1131-5. PubMed ID: 26297700
[TBL] [Abstract] [Full Text] [Related]
12. Effect of art making on cancer-related symptoms of blood and marrow transplantation recipients.
Lawson LM; Williams P; Glennon C; Carithers K; Schnabel E; Andrejack A; Wright N
Oncol Nurs Forum; 2012 Jul; 39(4):E353-60. PubMed ID: 22750906
[TBL] [Abstract] [Full Text] [Related]
13. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline xpd and XRCC3 homozygous polymorphisms.
Diamond HR; Ornellas MH; Orfao A; Gomes BE; Campos MM; Fernandez TS; da Silva RI; Alves G; Lage C; da Silva DA; Moellmann-Coelho A; da Cruz GS; Bouzas LF; Abdelhay E
J Hematol Oncol; 2011 Sep; 4():39. PubMed ID: 21951951
[TBL] [Abstract] [Full Text] [Related]
14. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
Guillem VM; Cervantes F; Martínez J; Alvarez-Larrán A; Collado M; Camós M; Sureda A; Maffioli M; Marugán I; Hernández-Boluda JC
Am J Hematol; 2010 Jul; 85(7):482-6. PubMed ID: 20575039
[TBL] [Abstract] [Full Text] [Related]
15. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.
Shi JY; Ren ZH; Jiao B; Xiao R; Yun HY; Chen B; Zhao WL; Zhu Q; Chen Z; Chen SJ
Int J Cancer; 2011 Jan; 128(1):233-8. PubMed ID: 20232390
[TBL] [Abstract] [Full Text] [Related]
16. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
[TBL] [Abstract] [Full Text] [Related]
17. Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
Martin MG; Augustin KM; Uy GL; Welch JS; Hladnik L; Goyal S; Tiwari D; Monahan RS; Reichley RM; Cashen AF; Stockerl-Goldstein K; Westervelt P; Abboud CN; Dipersio JF; Vij R
Am J Hematol; 2009 Nov; 84(11):733-7. PubMed ID: 19806665
[TBL] [Abstract] [Full Text] [Related]
18. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.
da Silva Silveira V; Canalle R; Scrideli CA; Queiroz RG; Bettiol H; Valera ET; Tone LG
Leuk Res; 2009 Jul; 33(7):898-901. PubMed ID: 19162321
[TBL] [Abstract] [Full Text] [Related]
19. DNA repair gene xpd and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract] [Full Text] [Related]
20. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia.
Weiss JR; Baer MR; Ambrosone CB; Blanco JG; Hutson A; Ford LA; Moysich KB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1038-41. PubMed ID: 17507636
[TBL] [Abstract] [Full Text] [Related]
[Next]
